Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepak Almeida

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Antimicrobial Agents and Chemotherapy|May 18, 2016
Mutations in pepQ Confer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosisDeepak Almeida, Thomas Ioerger, Sandeep Tyagi, et al.
Antimicrobial Agents and Chemotherapy|July 28, 2006
Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosisEric Nuermberger, Ian Rosenthal, Sandeep Tyagi, et al.
Pharmaceutics|January 21, 2022
Quantitative Analysis of the Phase Transition Mechanism Underpinning the Systemic Self-Assembly of a Mechanopharmaceutical DeviceSteven Dunne, Andrew R Willmer, Rosemary Swanson, et al.
Pharmaceutics|January 21, 2022
An Adaptive Biosystems Engineering Approach towards Modeling the Soluble-to-Insoluble Phase Transition of ClofazimineAndrew R Willmer, Steven Dunne, Rosemary Swanson, et al.
Antimicrobial Agents and Chemotherapy|June 6, 2012
Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosisIan M Rosenthal, Rokeya Tasneen, Charles A Peloquin, et al.
Antimicrobial Agents and Chemotherapy|November 21, 2018
High-Dose Rifamycins Enable Shorter Oral Treatment in a Murine Model of Mycobacterium ulcerans DiseaseTill F Omansen, Deepak Almeida, Paul J Converse, et al.
The Indian Journal of Medical Research|January 5, 2013
Activity of 5-chloro-pyrazinamide in mice infected with Mycobacterium tuberculosis or Mycobacterium bovisZahoor Ahmad, Sandeep Tyagi, Austin Minkowsk, et al.
Antimicrobial Agents and Chemotherapy|December 9, 2024
Contribution of telacebec to novel drug regimens in a murine tuberculosis modelOliver D Komm, Sandeep Tyagi, Andrew Garcia, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2012
Modeling early bactericidal activity in murine tuberculosis provides insights into the activity of isoniazid and pyrazinamideJacques Grosset, Deepak Almeida, Paul J Converse, et al.
Journal of Clinical Microbiology|February 26, 2016
Direct Susceptibility Testing of Mycobacterium tuberculosis for Pyrazinamide by Use of the Bactec MGIT 960 SystemAnne-Marie Demers, Amour Venter, Sven O Friedrich, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|May 18, 2016
Mutations in pepQ Confer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosisDeepak Almeida, Thomas Ioerger, Sandeep Tyagi, et al.
Antimicrobial Agents and Chemotherapy|July 28, 2006
Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosisEric Nuermberger, Ian Rosenthal, Sandeep Tyagi, et al.
Pharmaceutics|January 21, 2022
Quantitative Analysis of the Phase Transition Mechanism Underpinning the Systemic Self-Assembly of a Mechanopharmaceutical DeviceSteven Dunne, Andrew R Willmer, Rosemary Swanson, et al.
Pharmaceutics|January 21, 2022
An Adaptive Biosystems Engineering Approach towards Modeling the Soluble-to-Insoluble Phase Transition of ClofazimineAndrew R Willmer, Steven Dunne, Rosemary Swanson, et al.
Antimicrobial Agents and Chemotherapy|June 6, 2012
Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosisIan M Rosenthal, Rokeya Tasneen, Charles A Peloquin, et al.
Antimicrobial Agents and Chemotherapy|November 21, 2018
High-Dose Rifamycins Enable Shorter Oral Treatment in a Murine Model of Mycobacterium ulcerans DiseaseTill F Omansen, Deepak Almeida, Paul J Converse, et al.
The Indian Journal of Medical Research|January 5, 2013
Activity of 5-chloro-pyrazinamide in mice infected with Mycobacterium tuberculosis or Mycobacterium bovisZahoor Ahmad, Sandeep Tyagi, Austin Minkowsk, et al.
Antimicrobial Agents and Chemotherapy|December 9, 2024
Contribution of telacebec to novel drug regimens in a murine tuberculosis modelOliver D Komm, Sandeep Tyagi, Andrew Garcia, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2012
Modeling early bactericidal activity in murine tuberculosis provides insights into the activity of isoniazid and pyrazinamideJacques Grosset, Deepak Almeida, Paul J Converse, et al.
Journal of Clinical Microbiology|February 26, 2016
Direct Susceptibility Testing of Mycobacterium tuberculosis for Pyrazinamide by Use of the Bactec MGIT 960 SystemAnne-Marie Demers, Amour Venter, Sven O Friedrich, et al.
Pageof 3